Lineage Cell Therapeutics
LCTX
#8509
Rank
ยฃ0.19 B
Marketcap
ยฃ0.77
Share price
-3.74%
Change (1 day)
-9.63%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -ยฃ17.01 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are ยฃ14.77 Million. In 2025 the company made an earning of -ยฃ16.36 Million a decrease over its 2024 earnings that were of -ยฃ16.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ17.01 Million4.02%
2025 -ยฃ16.36 Million1.4%
2024 -ยฃ16.13 Million-13.16%
2023 -ยฃ18.58 Million9.83%
2022 -ยฃ16.91 Million-54.24%
2021 -ยฃ36.95 Million86.07%
2020 -ยฃ19.86 Million-31.97%
2019 -ยฃ29.19 Million-5.42%
2018 -ยฃ30.87 Million1.1%
2017 -ยฃ30.53 Million-31.06%
2016 -ยฃ44.28 Million-10.38%
2015 -ยฃ49.41 Million29.69%
2014 -ยฃ38.1 Million31.68%
2013 -ยฃ28.94 Million
2011 -ยฃ14.05 Million89.78%
2010 -ยฃ7.4 Million206.06%
2009 -ยฃ2.42 Million-0.58%
2008 -ยฃ2.44 Million164.89%
2007 -ยฃ0.92 Million-30.22%
2006 -ยฃ1.32 Million
2002 -ยฃ1.53 Million-41.04%
2001 -ยฃ2.6 Million-32.04%
2000 -ยฃ3.82 Million-11.85%
1999 -ยฃ4.33 Million
1997 -ยฃ2.78 Million12.12%
1996 -ยฃ2.48 Million106.25%
1995 -ยฃ1.21 Million-11.11%
1994 -ยฃ1.36 Million50%
1993 -ยฃ0.91 Million20%
1992 -ยฃ0.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.12 Billion 555.55%๐Ÿ‡บ๐Ÿ‡ธ USA